His primary areas of study are Melanoma, Surgery, Sentinel lymph node, Lymph node and Internal medicine. His research in Melanoma is mostly concerned with Cutaneous melanoma. The concepts of his Surgery study are interwoven with issues in Cancer and Breast cancer.
The concepts of his Sentinel lymph node study are interwoven with issues in Lymphovascular invasion, Metastasis, Lymph and Biopsy, Radiology. Merrick I. Ross has included themes like Wide local excision, Predictive value of tests, Nuclear medicine, Lymphatic system and Dissection in his Lymph node study. Merrick I. Ross has researched Internal medicine in several fields, including Gastroenterology and Oncology.
His primary areas of investigation include Melanoma, Surgery, Internal medicine, Oncology and Sentinel lymph node. His Melanoma research is multidisciplinary, incorporating elements of Stage, Radiology and Lymph node, Pathology. His research in Surgery intersects with topics in Cancer, Breast cancer and Lymphadenectomy.
When carried out as part of a general Internal medicine research project, his work on Surgical oncology, Primary tumor and Clinical trial is frequently linked to work in In patient, therefore connecting diverse disciplines of study. His research investigates the link between Oncology and topics such as Ipilimumab that cross with problems in Phases of clinical research. His research investigates the connection between Sentinel lymph node and topics such as Biopsy that intersect with issues in Sentinel node and Lymphatic mapping.
Merrick I. Ross mainly investigates Internal medicine, Melanoma, Oncology, Talimogene laherparepvec and Phases of clinical research. Merrick I. Ross merges many fields, such as Internal medicine and In patient, in his writings. His Melanoma study incorporates themes from Stage, Sentinel lymph node, Targeted therapy and Lymph node.
Merrick I. Ross interconnects Biopsy and Radiology in the investigation of issues within Sentinel lymph node. Merrick I. Ross focuses mostly in the field of Lymph node, narrowing it down to matters related to Dissection and, in some cases, Metastasis. His Oncology study combines topics in areas such as Cancer, Adjuvant therapy, Primary tumor and Cutaneous melanoma.
His primary scientific interests are in Internal medicine, Oncology, Melanoma, Talimogene laherparepvec and Phases of clinical research. Metastatic melanoma is closely connected to Immunology in his research, which is encompassed under the umbrella topic of Internal medicine. In the field of Oncology, his study on Adjuvant overlaps with subjects such as Clinical Practice.
His study in Melanoma is interdisciplinary in nature, drawing from both Stage, Surgery, Biopsy and Gastroenterology. His study connects Sentinel lymph node and Biopsy. His work carried out in the field of Cutaneous melanoma brings together such families of science as Interferon alfa and Lymph node.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch;Jeffrey E. Gershenwald;Seng Jaw Soong;John F. Thompson.
Journal of Clinical Oncology (2009)
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H.I. Andtbacka;Howard L. Kaufman;Frances Collichio;Thomas Amatruda.
Journal of Clinical Oncology (2015)
Genomic Classification of Cutaneous Melanoma
Rehan Akbani;Kadir C. Akdemir;B. Arman Aksoy;Monique Albert.
Cell (2015)
Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy
Henry M. Kuerer;Lisa A. Newman;Terry L. Smith;Fred C. Ames.
Journal of Clinical Oncology (1999)
Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.
Jeffrey E. Gershenwald;William Thompson;Paul F. Mansfield;Jeffrey E. Lee.
Journal of Clinical Oncology (1999)
The orderly progression of melanoma nodal metastases.
Douglas Reintgen;C. Cruse;Karen Wells;Claudia Berman.
Annals of Surgery (1994)
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger.
Charles M. Balch;Seng Jaw Soong;Alfred A. Bartolucci;Marshall M. Urist.
Annals of Surgery (1996)
Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma
John Albertini;C. Cruse;David Rapaport;Karen Wells.
Annals of Surgery (1996)
Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.
Jeffrey E. Gershenwald;Maria I. Colome;Jeffrey E. Lee;Paul F. Mansfield.
Journal of Clinical Oncology (1998)
Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)
Charles M. Balch;Seng Jaw Soong;Merrick I. Ross;Marshall M. Urist.
Annals of Surgical Oncology (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
University of South Florida
University of Louisville
University of Modena and Reggio Emilia
University of Oslo
ParkerVision
Sun Yat-sen University
Instituto Superior Técnico
University of Rochester
University of Science and Technology of China
Indian Institute of Information Technology, Design & Manufacturing, Kurnool
University of Waterloo
Nippon Medical School
University of Western Australia
University of Oregon
University of Malawi
Texas A&M University
George Washington University
City, University of London